Variation in Anticoagulation Prophylaxis Practice After Fontan: A Call for a National Fontan Registry

To the Editor, We read with great interest the recent publication by Anderson et al. [1] on the inconsistencies in medication therapy among Fontan patients across seven pediatric heart networks in the United States. The practice in the United Kingdom appears to reflect a similar treatment dilemma. We conducted a survey of consultant pediatric cardiologists, with 20 respondents representing 13 different pediatric cardiology centers in the United...